Sterigenics has increased gamma sterilization capacity in Fort Worth, Texas.
Sterigenics International, LLC has completed a $17.5-million expansion to its gamma sterilization capacity in Fort Worth, TX. Included in the project is the installation of a gamma irradiator that, with other new features, will boost the facility’s total sterilization throughput by 60%, adding 50,000 pallets per year in capacity, 20 new employees, and 60,000 ft2 to the building’s footprint.
To address the growing need for sterilization for pharmaceuticals, medical devices, and other industries in many parts of the world, Sterigenics is making significant investments in technology to expand both gamma and ethylene oxide (EO) capacity throughout its global network. In June 2017, Sterigenics completed a project that tripled throughput at its operation in West Memphis, AR, for gamma sterilization. Sterigenics also has expansion projects underway at its EO facilities in California; Costa Rica; and Wiesbaden, Germany.
Source: Sterigenics
Understanding the Variability in Bioburden Test Results in Biomanufacturing
May 7th 2025This article explores the impact of test volume, microbial distribution, and dilution errors on bioburden testing variability. It presents statistical approaches to estimate percentage error and discusses strategies to optimize microbial enumeration techniques in biopharmaceutical quality control.
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Trump Directs FDA, EPA to Reduce Regulatory Barriers to Domestic Pharma Manufacturing
May 7th 2025The White House is instructing FDA to increase fees for and inspections of foreign drug manufacturing plants and reduce the time required to approve such sites that will be newly constructed in the US.
Intertek to Expand UK GMP Facility with 6000 Square Feet of Lab and Office Space
May 7th 2025The company said the expansion is in response to globally rising demand for inhaled biologics, which offer distinct advantages in route of administration, but can be challenging products for developers.